A cannabis-based medicine can now be prescribed to sufferers of a rare genetic condition which causes seizures as part of a raft of drugs approved for use on the Scottish health service. Epidyolex, or cannabidiol, was approved by the Scottish Medicines Consortium( SMC) on Monday for use on patients as young as two years old with seizures associated with tuberous sclerosis complex, a rare genetic condition which requires round the clock care and impacts on all aspects of life. Consortium chairman

“ HHS should consider using march-in rights when drugs face limited competition or market practices have failed to ensure an affordable price, ensuring that prescription drugs invented with taxpayer dollars are reasonably priced and affordable.” Support our journalism.... Advocates of “ march-in ” mutter darkly that both men were in the pay of the pharmaceutical industry at the time. The Trump administration sought to settle the dispute with a last-minute regulation, issued in January, that rea